Fusion Antibodies plc
FAB.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£512 | -£955 | -£758 | -£869 |
| Dep. & Amort. | £62 | £45 | £60 | £94 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £11 | £24 | £0 |
| Change in WC | -£139 | -£35 | £151 | £5 |
| Other Non-Cash | £14 | £322 | -£229 | £351 |
| Operating Cash Flow | -£575 | -£612 | -£752 | -£419 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£60 | -£10 | £0 | -£2 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £1 | £4 | £0 |
| Investing Cash Flow | -£60 | -£9 | £4 | -£2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£40 | -£12 | -£11 | -£5 |
| Stock Issued | £568 | £555 | £0 | £1,136 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | -£1 | £0 | £0 |
| Financing Cash Flow | £528 | £542 | -£11 | £1,131 |
| Forex Effect | £0 | -£1 | £1 | £2 |
| Net Chg. in Cash | -£107 | -£80 | -£760 | £712 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £359 | £439 | £1,199 | £487 |
| End Cash | £252 | £359 | £439 | £1,199 |
| Free Cash Flow | -£635 | -£622 | -£752 | -£421 |